Prediction of infarct growth based on apparent diffusion coefficients: Penumbral assessment without intravenous contrast material

Radiology

Volumn 250, Issue 1, 2009, Pages 184-192

  Rosso, Charlotte ^a,b   Hevia Montiel, Nidiyare ^b   Deltour, Sandrine ^a   Bardinet, Eric ^b,c   Dormont, Didier ^a,b   Crozier, Sophie ^a   Baillet, Sylvain ^b   Samson, Yves ^a  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b Centre National de la Recherche Scientifique   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR; CONTRAST MEDIUM;

ADULT; AGED; ARTICLE; BRAIN ANGIOGRAPHY; BRAIN INFARCTION; BRAIN INFARCTION SIZE; DIFFUSION WEIGHTED IMAGING; FOLLOW UP; HUMAN; IMAGING SYSTEM; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PRIORITY JOURNAL; STROKE; CEREBRAL ARTERY DISEASE; DISEASE COURSE; FEASIBILITY STUDY; FEMALE; IMAGE PROCESSING; MALE; MIDDLE AGED; PROGNOSIS; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; CONTRAST MEDIA; DIFFUSION MAGNETIC RESONANCE IMAGING; DISEASE PROGRESSION; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; INFARCTION, MIDDLE CEREBRAL ARTERY; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; PROGNOSIS; RISK FACTORS;

EID: 58149359691     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.2493080107     Document Type: Article

References (35)

1. Albers GW. Expanding the window for thrombolytic therapy in acute stroke: the potential role of acute MRI for patient selection. Stroke 1999;30:2230-2237.
2. Albers GW, Thijs VN, Wechsler L, et al. Magnetic resonance imaging profiles predict clinical response to early reperfusion: the Diffusion and Perfusion Imaging Evaluation for Understanding Stroke Evolution (DEFUSE) Study. Ann Neurol 2006;60:508- 517.
3. Warach S. Use of diffusion and perfusion magnetic resonance imaging as a tool in acute stroke clinical trials. Curr Control Trials Cardiovasc Med 2001;2:38-44.
4. Phan TG, Donnan GA, Davis SM, Byrnes G; and MR Stroke Collaborative Group. Proof-of-principle phase II MRI studies in stroke: sample size estimates from dichotomous and continuous data. Stroke 2006;37:2521- 2525.
5. Barber PA, Parsons MW, Desmond PM, et al. The use of PWI and DWI measures in the design of "proof of concept" trials. J Neuroimaging 2004;14:123-132.
6. Neumann-Haefelin T, Wittsack HJ, Wenserski F, et al. Diffusion- and perfusion-weighted MRI: the DWI/PWI mismatch region in acute stroke. Stroke 1999;30:1591-1597.
7. Sorensen AG, Buonanno FS, Gonzalez RG, et al. Hyperacute stroke: evaluation with combined multisection diffusion-weighted and hemodynamically weighted echo-planar MR imaging. Radiology 1996;199:391- 401.
8. Lansberg MG, Thijs VN, Hamilton S, et al. Evaluation ofthe clinical-diffusion and perfusion-diffusion mismatch models in DEFUSE. Stroke 2007;38:1826-1830.
9. Oppenheim C, Grandin C, Samson Y, et al. Is there an apparent diffusion coefficient threshold in predicting tissue viability in hy- peracute stroke? Stroke 2001;32:2486-2491.
10. Sobesky J, Weber OZ, Lehnhardt FG, et al. Does the mismatch match the penumbra? MRI and PET in early ischemic stroke. Stroke 2005;36:980-985.
11. Butcher KS, Parsons M, MacGregor L, et al. Refining the perfusion-diffusion mismatch hypothesis. Stroke 2005;36:1153-1159.
12. Keir SL, Wardlaw JM. Systematic review of diffusion and perfusion imaging in acute is- chemic stroke. Stroke 2000;31:2723-2731.
13. Kane I, Sandercock P, Wardlaw J. Magnetic resonance perfusion diffusion mismatch and thrombolysis in acute ischaemic stroke: a systematic review of the evidence to date. J Neurol Neurosurg Psychiatry 2007;78: 485- 491.
14. Hacke W, Furlan A; for the DIAS-2 Investigators. Results from the Phase III Study of Desmoteplase in Acute Ischemic Stroke Trial 2 (DIAS 2) [abstr]. Cerebrovasc Dis 2007; 23(suppl 2):54.
15. Davis SM, Donnan GA, Parsons MW, et al. Effects ofalteplase beyond3hafterstrokein the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol 2008;7: 299-309.
16. Detre JA, Zager EL, Alsop DC, Harris VA, Welsh FA. Correlation of diffusion MRI and heat shock protein in a rat embolic stroke model. J Neurol Sci 1997;148:163-169.
17. Sakoh M, Ostergaard L, Gjedde A, et al. Prediction of tissue survival after middle cerebral artery occlusion based on changes in the apparent diffusion ofwater. J Neurosurg 2001;95:450-458.
18. Na DG, Thijs VN, Albers GW, Moseley ME, Marks MP. Diffusion-weighted MR imaging in acute ischemia: value of apparent diffusion coefficient and signal intensity thresholds in predicting tissue at risk and final infarct size. AJNR Am J Neuroradiol 2004;25:1331- 1336.
19. Schaefer PW, Ozsunar Y, He J, et al. Assessing tissue viability with MR diffusion and per- fusion imaging. AJNR Am J Neuroradiol 2003;24:436-443.
20. Hevia-Montiel N, Rosso C, Chupin M, et al. Automatic prediction of final infarct growth in acute ischemic stroke from MR apparent diffusion coefficient maps. Int J Comput Assist RadiolSurg 2006;1:115-117.
21. Rosso C, Hevia-Montiel N, Deltour S, et al. A new DWI-based method of MCA infarct growth prediction during the therapeutic window [abstr]. Stroke 2007;38(P11):488.
22. Parsons MW, Yang Q, Barber A, et al. Per- fusion magnetic resonance imaging maps in hyperacute strokes: relative cerebral blood flow most accurately identifies tissue destined to infarct. Stroke 2001;32:1581-1587.
23. Schellinger PD, Jansen O, Fiebach JB, et al. Monitoring intravenous recombinant tissue plasminogen activator thrombolysis for acute ischemic stroke with diffusion and perfusion MRI. Stroke 2000;31:1318-1328.
24. Barber PA, Darby DG, Desmond PM, et al. Prediction of stroke outcome with echopla- nar perfusion- and diffusion-weighted MRI. Neurology 1998;51:418-426.
25. Beaulieu C, de Crespigny A, Tong DC, Moseley ME, Albers GW, Marks MP. Longitudinal magnetic resonance imaging study of perfusion and diffusion in stroke: evolution of lesion volume and correlation with clinical outcome. Ann Neurol 1999;46:568-578.
26. Rordorf G, Koroshetz WJ, Copen WA, et al. Regional ischemia and ischemic injury in patients with acute middle cerebral artery stroke as defined by early diffusion-weighted and perfusion-weighted MRI. Stroke 1998; 29:939-943.
27. Parsons MW, Barber PA, Chalk J, et al. Diffusion- and perfusion-weighted MRI response to thrombolysis in stroke. Ann Neurol2002;51:28-37.
28. Shih LC, Saver JL, Alger JR, et al. Perfusion- weighted magnetic resonance imaging thresholds identifying core, irreversibly infarcted tissue. Stroke 2003;34:1425-1430.
29. Thijs VN, Adami A, Neumann-Haefelin T, Moseley ME, Albers GW. Clinicaland radiological correlates of reduced cerebral blood flow measured using magnetic resonance imaging. Arch Neurol2002;59:233-238.
30. Rose SE, Janke AL, Griffin M, Finnigan S, Chalk JB. Improved prediction of final infarct volume using bolus delay-corrected perfu- sion-weighted MRI: implications for the is- chemic penumbra. Stroke 2004;35:2466-2471.
31. DerexL, NighoghossianN, HermierM, et al. Influence of pretreatment MRI parameters on clinical outcome, recanalization and in- farct size in 49 stroke patients treated by intravenous tissue plasminogen activator. J NeurolSci 2004;225:3-9.
32. Schellinger PD, Fiebach JB, Jansen O, et al. Stroke magnetic resonance imaging within 6 hours after onset of hyperacute cerebral ischemia. Ann Neurol2001;49:460-469.
33. Röther J, Schellinger PD, Gass A, et al. Effect of intravenous thrombolysis on MRI parameters and functional outcome in acute stroke < 6 hours. Stroke 2002;33:2438-2445.
34. Minematsu K, Li L, Sotak CH, Davis MA, Fisher M. Reversible focal ischemic injury demonstrated by diffusion-weighted magnetic resonance imaging in rats. Stroke 1992;23:1304-1310.
35. Fiehler J, Foth M, Kucinski T, et al. Severe ADC decreases do not predict irreversible damages in humans. Stroke 2002;33:79-86.